Momenta Pharmaceuticals Shares Up 7% Following News Compliance Status For Co.'s McPherson, Kansas Facility Was Amended To Voluntary Action Indicated, Suggesting 'potential for the near-term FDA approval of Sandoz's Glatopa 40 mg ANDA'
Paul Quintaro